Cancer Research UK invests £1.7m in Leicester to turn lab discoveries into new cancer drugs

Posted by ap507 at Oct 07, 2015 09:25 AM |
Cancer Research UK has invested £15 million to inspire collaborative cancer research between scientists across the UK through a new awards scheme launched today

CANCER RESEARCH UK has awarded the University of Leicester £1.7 million through a new Centres Network Accelerator Award for research to crack the structure of molecules involved in cancer and to develop new drugs.

The Centres Network Accelerator Award is a new initiative by Cancer Research UK and provides additional infrastructure to research centres in order to unite scientists, boost collaborative research and inspire ‘bench to bedside’ science.

The award will be given over five years and aims to create high-quality data in structural biology – the 3D information about molecules involved in cancer. And increase collaboration between scientists to generate new ideas and make the most of shared resources. The award will focus on research that brings the understanding of structural biology to drugs that could treat patients.

The rise of personalised medicine means that patients can receive different drugs and treatments depending on their genetic fingerprint. Cancer Research UK has invested in research to identify drug targets for different groups of patients, but turning those discoveries into new tests and treatments needs more research.

University of Leicester will combine expertise with the Institute of Cancer Research, University of Manchester, Newcastle University, University of Glasgow, Queens University Belfast, and University of Leeds.

Professor Catrin Pritchard, science director at the Cancer Research UK Leicester Centre, said: “Personalised medicine is the future of cancer treatment, and by collaborating with centres across the UK, we look forward to accelerating research underpinning drug development. Making the most of our resources in structural biology across the network is crucial to making sure science in the laboratory turns into treatments for patients.”

Dr David Scott, Cancer Research UK’s director of science funding, said: “Effective partnerships are crucial for delivering the greatest science and boosting advancements in fighting cancer. We’re proud to invest in collaborative and innovative research across the UK with the new Centres Network Accelerator awards.  It’s through working together and uniting expertise that we will do better research and save more lives.”

ENDS

For media enquiries contact Stephanie McClellan in the Cancer Research UK press office on 020 3469 5314

Notes to editor:

* The Centres Network Accelerator Award is designed to unite Cancer Research UK’s research centres to support research across networks, not solely as individual centres. These awards provide additional infrastructure to centres to boost research and ‘bench to bedside’ translational science.

The University of Leicester is a leading UK University committed to international excellence through the creation of world changing research and high quality, inspirational teaching. Leicester is consistently one of the UK's most socially inclusive universities with a long-standing commitment to providing fairer and equal access to higher education. Leicester is a three-time winner of the Queen’s Anniversary Prize for Higher and Further Education and is the only University to win seven consecutive awards from the Times Higher. Leicester is ranked among the top one per-cent of universities in the world by the THE World University Rankings.

About Cancer Research UK

  • Cancer Research UK is the world’s leading cancer charity dedicated to saving lives through research.
  • Cancer Research UK’s pioneering work into the prevention, diagnosis and treatment of cancer has helped save millions of lives.
  • Cancer Research UK receives no government funding for its life-saving research. Every step it makes towards beating cancer relies on every pound donated.
  • Cancer Research UK has been at the heart of the progress that has already seen survival in the UK double in the last forty years.
  • Today, 2 in 4 people survive their cancer for at least 10 years. Cancer Research UK’s ambition is to accelerate progress so that 3 in 4 people will survive their cancer for at least 10 years within the next 20 years.
  • Cancer Research UK supports research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses.
  • Together with its partners and supporters, Cancer Research UK's vision is to bring forward the day when all cancers are cured. 

For further information about Cancer Research UK's work or to find out how to support the charity, please call 0300 123 1022 or visit www.cancerresearchuk.org. Follow us on Twitter and Facebook.

 

Share this page: